Lincoln Medical

Anapen® is a registered trademark for a commonly used autoinjector of epinephrine (a.k.a. adrenaline), used to reverse anaphylactic shock.

Anapens are commonly carried by persons with severe allergies and a risk of anaphylactic shock because they can be self-administered and are very fast-acting.

Anapens are regulated medicinal products and require a medical prescription in all countries.

The Anapen contains a prefilled needle syringe combination which delivers adrenaline intramuscularly.


Anapen 150

Anapen® 150 was approved by the Medicines and Healthcare Products Regulatory Agency in London for the UK in July 2001.

By March 2003 Anapen 150 was approved in France, in Germany, in Sweden and in Ireland.

Further approvals were granted in 2005 in a number of other European Countries and subsequently in Canada, Australia and New Zealand.

New registrations are still runnning in a number of countries.



Shelf life

At manufacture has a shelf life of 21months.

Anapen shipment and expiry notices

Copyright © 2009